Found: 7
Select item for more details and to access through your institution.
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 7, p. 647, doi. 10.3390/ph14070647
- By:
- Publication type:
- Article
MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Consistent Inhibition of Cyclooxygenase Drives Macrophages towards the Inflammatory Phenotype.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118203
- By:
- Publication type:
- Article
Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063451
- By:
- Publication type:
- Article
Barium Titanate Nanoparticles Sensitise Treatment-Resistant Breast Cancer Cells to the Antitumor Action of Tumour-Treating Fields.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59445-x
- By:
- Publication type:
- Article
Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-57496-8
- By:
- Publication type:
- Article
MKI-1, a Novel Small-Molecule Inhibitor of MASTL, Exerts Antitumor and Radiosensitizer Activities Through PP2A Activation in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.571601
- By:
- Publication type:
- Article